Hod Assaf Industries Ltd
TASE:HOD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hod Assaf Industries Ltd
TASE:HOD
|
IL |
|
D
|
Denis Chem Lab Ltd
BSE:537536
|
IN |
|
W
|
Walchand Peoplefirst Ltd
BSE:501370
|
IN |
|
E
|
ExpertAi SpA
MIL:EXAI
|
IT |
|
Nemak SAB de CV
BMV:NEMAKA
|
MX |
|
Torrid Holdings Inc
NYSE:CURV
|
US |
|
T Spiritual World Ltd
BSE:532444
|
IN |
|
Identiv Inc
NASDAQ:INVE
|
US |
|
S
|
Saboo Sodium Chloro Ltd
BSE:530461
|
IN |
|
T
|
Thor Medical ASA
OSE:TRMED
|
NO |
|
Borusan Yatirim ve Pazarlama AS
IST:BRYAT.E
|
TR |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
Indutrade AB
STO:INDT
|
SE |
|
M
|
Meyar Co
SAU:9565
|
SA |
|
Agency Group Australia Ltd
ASX:AU1
|
AU |
|
SSE PLC
LSE:SSE
|
UK |
|
Kerry Group PLC
ISEQ:KRZ
|
IE |
|
T
|
Torrent Gold Inc
CNSX:TGLD
|
CA |
|
A
|
Arad Investment & Industrial Development Ltd
TASE:ARAD
|
IL |
Balance Sheet
Balance Sheet Decomposition
Hod Assaf Industries Ltd
Hod Assaf Industries Ltd
Balance Sheet
Hod Assaf Industries Ltd
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
1
|
8
|
14
|
10
|
10
|
12
|
22
|
8
|
13
|
16
|
8
|
16
|
10
|
17
|
35
|
7
|
5
|
14
|
9
|
13
|
14
|
24
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
1
|
8
|
14
|
10
|
10
|
12
|
22
|
8
|
13
|
16
|
0
|
16
|
10
|
17
|
35
|
7
|
5
|
14
|
9
|
13
|
14
|
24
|
|
| Total Receivables |
164
|
179
|
200
|
214
|
312
|
363
|
245
|
211
|
270
|
324
|
286
|
283
|
300
|
232
|
227
|
261
|
360
|
338
|
321
|
327
|
464
|
383
|
422
|
|
| Accounts Receivables |
158
|
169
|
179
|
188
|
285
|
331
|
216
|
200
|
242
|
298
|
276
|
279
|
281
|
218
|
212
|
244
|
339
|
315
|
301
|
309
|
452
|
365
|
415
|
|
| Other Receivables |
6
|
10
|
21
|
26
|
27
|
33
|
29
|
12
|
28
|
26
|
10
|
4
|
19
|
13
|
15
|
17
|
22
|
23
|
20
|
19
|
13
|
18
|
7
|
|
| Inventory |
114
|
87
|
165
|
200
|
220
|
247
|
192
|
154
|
200
|
306
|
289
|
264
|
262
|
223
|
218
|
257
|
320
|
343
|
271
|
443
|
400
|
465
|
424
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
0
|
5
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
7
|
3
|
5
|
9
|
|
| Total Current Assets |
280
|
267
|
373
|
428
|
542
|
620
|
449
|
387
|
481
|
649
|
590
|
560
|
577
|
477
|
462
|
553
|
687
|
687
|
606
|
787
|
879
|
866
|
878
|
|
| PP&E Net |
92
|
105
|
116
|
131
|
184
|
379
|
235
|
226
|
233
|
241
|
280
|
294
|
293
|
258
|
272
|
296
|
341
|
362
|
354
|
337
|
353
|
359
|
383
|
|
| PP&E Gross |
92
|
105
|
116
|
131
|
184
|
379
|
235
|
226
|
233
|
241
|
280
|
294
|
293
|
0
|
0
|
0
|
0
|
0
|
0
|
337
|
353
|
359
|
383
|
|
| Accumulated Depreciation |
108
|
130
|
150
|
162
|
188
|
21
|
32
|
51
|
73
|
93
|
113
|
137
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
362
|
399
|
452
|
499
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
0
|
0
|
23
|
8
|
13
|
27
|
24
|
13
|
3
|
3
|
3
|
12
|
5
|
5
|
5
|
5
|
10
|
8
|
13
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
42
|
14
|
2
|
6
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
3
|
0
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
373
N/A
|
373
+0%
|
490
+31%
|
560
+14%
|
726
+30%
|
1 004
+38%
|
750
-25%
|
636
-15%
|
731
+15%
|
924
+27%
|
898
-3%
|
866
-4%
|
873
+1%
|
739
-15%
|
738
0%
|
863
+17%
|
1 034
+20%
|
1 057
+2%
|
968
-8%
|
1 129
+17%
|
1 243
+10%
|
1 235
-1%
|
1 274
+3%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
53
|
66
|
115
|
127
|
147
|
147
|
73
|
97
|
126
|
132
|
83
|
75
|
122
|
45
|
55
|
88
|
123
|
79
|
66
|
99
|
105
|
114
|
114
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
34
|
31
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
57
|
53
|
50
|
58
|
|
| Short-Term Debt |
205
|
163
|
182
|
186
|
256
|
297
|
96
|
14
|
48
|
248
|
196
|
193
|
189
|
0
|
0
|
41
|
242
|
311
|
197
|
148
|
292
|
315
|
269
|
|
| Current Portion of Long-Term Debt |
2
|
5
|
6
|
11
|
11
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
78
|
56
|
20
|
20
|
26
|
20
|
19
|
15
|
8
|
13
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
24
|
19
|
62
|
38
|
83
|
62
|
56
|
100
|
103
|
154
|
103
|
82
|
138
|
161
|
96
|
45
|
38
|
|
| Total Current Liabilities |
260
|
233
|
303
|
325
|
414
|
456
|
193
|
130
|
236
|
418
|
396
|
361
|
367
|
223
|
215
|
303
|
489
|
499
|
422
|
483
|
562
|
532
|
492
|
|
| Long-Term Debt |
19
|
41
|
40
|
60
|
57
|
58
|
35
|
23
|
11
|
2
|
0
|
0
|
0
|
50
|
36
|
47
|
26
|
37
|
25
|
11
|
14
|
9
|
22
|
|
| Deferred Income Tax |
1
|
1
|
1
|
5
|
5
|
49
|
37
|
17
|
19
|
24
|
14
|
16
|
13
|
7
|
11
|
13
|
13
|
14
|
17
|
12
|
11
|
9
|
6
|
|
| Minority Interest |
1
|
1
|
1
|
1
|
4
|
7
|
3
|
3
|
4
|
4
|
5
|
6
|
5
|
5
|
5
|
5
|
6
|
6
|
8
|
8
|
7
|
5
|
6
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
3
|
3
|
4
|
4
|
3
|
3
|
4
|
4
|
4
|
2
|
2
|
2
|
2
|
22
|
3
|
3
|
4
|
3
|
3
|
|
| Total Liabilities |
280
N/A
|
276
-1%
|
344
+25%
|
391
+14%
|
483
+24%
|
572
+18%
|
272
-52%
|
177
-35%
|
273
+54%
|
451
+65%
|
418
-7%
|
386
-8%
|
389
+1%
|
289
-26%
|
270
-6%
|
371
+37%
|
536
+45%
|
578
+8%
|
475
-18%
|
518
+9%
|
597
+15%
|
559
-6%
|
531
-5%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
|
| Retained Earnings |
70
|
75
|
123
|
147
|
221
|
408
|
410
|
391
|
390
|
406
|
412
|
413
|
416
|
382
|
414
|
439
|
443
|
430
|
444
|
567
|
598
|
625
|
694
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
14
|
13
|
18
|
18
|
23
|
20
|
17
|
19
|
|
| Total Equity |
93
N/A
|
97
+5%
|
146
+50%
|
169
+16%
|
243
+44%
|
431
+77%
|
478
+11%
|
459
-4%
|
457
0%
|
473
+3%
|
480
+1%
|
480
+0%
|
484
+1%
|
450
-7%
|
468
+4%
|
492
+5%
|
498
+1%
|
480
-4%
|
493
+3%
|
611
+24%
|
646
+6%
|
676
+5%
|
743
+10%
|
|
| Total Liabilities & Equity |
373
N/A
|
373
+0%
|
490
+31%
|
560
+14%
|
726
+30%
|
1 004
+38%
|
750
-25%
|
636
-15%
|
731
+15%
|
924
+27%
|
898
-3%
|
866
-4%
|
873
+1%
|
739
-15%
|
738
0%
|
863
+17%
|
1 034
+20%
|
1 057
+2%
|
968
-8%
|
1 129
+17%
|
1 243
+10%
|
1 235
-1%
|
1 274
+3%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
|